Often, when a patient is following a long-term gluten-free diet with good compliance, micronutrient deficiencies cannot be detected. This review – published in the scientific journal Medicina – evaluates the most recent literature on micronutrient deficiencies in patients following a long-term gluten-free diet in order to provide dietary supplementation advice. The study concludes that in…

The Celiac Disease Foundation is proud to announce that Bradley J. Herrema, Secretary of the Foundation’s Board of Directors, has been selected for recognition as one the 2020 Best Lawyers in America.

A study published by the Journal of the American Medical Association (JAMA) concluded that higher gluten intake during the first 5 years of life is correlated with an increased risk of celiac disease among children who possess the HLA genes associated with celiac disease. The study was conducted in research centers in the United States, Finland, Germany, and Sweden.

The Celiac Disease Foundation was proud to be an endorsement partner of the 2019 James W. Freston Conference – Food at the Intersection of Gut Health and Disease to educate physicians on the latest research on celiac disease management. On August 9-10, 2019, Director of Research and Advocacy, Julia McBeth, attended the conference in Chicago,…

On August 13th, 2019, Innovate Biopharmaceuticals, Inc. (Innovate) announced the first patient has been dosed in its Phase 3 clinical trial for patients with celiac disease. The CeD LA 3001 trial is testing larazotide acetate—also known as INN-202—as an adjunct treatment for patients with celiac disease still experiencing symptoms on a gluten-free diet. Larazotide acetate…

Proud Sponsor Enjoy Life has partnered with the Celiac Disease Foundation to make a positive impact this Back-to-School season.

Researchers are collecting blood samples to learn more about the antigens that cause certain T cells to trigger intestinal damage in celiac disease patients. Complete a 30-minute study from home & be compensated $50 for your time.

I’m writing to invite you to join me and others from across the healthcare community at the 2019 Patient-Centered Outcomes Research Institute (PCORI) Annual Meeting, being held September 18-20 at the Marriott Wardman Park Hotel in Washington, DC. As a member of PCORI’s Advisory Panel on Patient Engagement, I know firsthand that PCORI’s staff is…

Written by Francisco Leon, MD, PhD, Chief Scientific Officer, Co-Founder, Provention Bio Current guidelines recommend routine follow-up for celiac disease with dietary interviews and celiac blood tests, though these methods are not accurate measures of gluten-free diet (GFD) adherence. A recent study in Spain tested the use of gluten immunogenic peptides (GIP)—a direct measure of…

All over the country, parents are getting ready to send their children back to school. Our children, Alexander Solomon, Amanda Solomon, and Draya Ramer, have celiac disease. Returning to school presents special challenges every year…challenges that are magnified if a child is starting a new school or even moving to a new classroom. That is why we are…